Market revenue in 2023 | USD 154.9 million |
Market revenue in 2028 | USD 221.0 million |
Growth rate | 7.4% (CAGR from 2023 to 2028) |
Largest segment | Polyethylene isosorbide terephthalate (peit) |
Fastest growing segment | Polyethylene Isosorbide Terephthalate (PEIT) |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Polyethylene Isosorbide Terephthalate (PEIT), Polycarbonate, Polyurethane, Polyester Polyisosorbide Succinate (PIS), Isosorbide Diester, Other Applications |
Key market players worldwide | Jiayin Group Inc ADR, Rocket Companies Inc Ordinary Shares Class A, J and K Scientific, Novaphene, Manus Aktteva Biopharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to isosorbide market will help companies and investors design strategic landscapes.
Polyethylene isosorbide terephthalate (peit) was the largest segment with a revenue share of 25.95% in 2023. Horizon Databook has segmented the Europe isosorbide market based on polyethylene isosorbide terephthalate (peit), polycarbonate, polyurethane, polyester polyisosorbide succinate (pis), isosorbide diester, other applications covering the revenue growth of each sub-segment from 2018 to 2028.
Bio-based materials, such as bio-based thermosets and bioplastics, are increasingly being used in automotive industry. The growing popularity of bio-concept cars is expected to boost the demand for isosorbide-based thermoplastics. The European Authorities are aiming to establish a bio-based sector, as well as numerous plans and policies aimed at achieving long-term economic growth, is expected to drive isosorbide demand in the region. Major factors driving the isosorbide market in the region include the circular economy package, European Innovation Partnerships (EIP), commission expert group for bio-based products, and other strategic initiatives.
In terms of employment generation and investment in drug development, Europe's pharmaceutical sector is a major contributor to the European economy. At the same time, as the population is aging, diseases and growing health impacts, such as the COVID-19 pandemic, are becoming more prevalent. Furthermore, as per the report published by the European Union based on the pharmaceutical strategy of Europe, the European pharmaceutical sector is robust and competitive, which is expected to promote the utilization of bio-based pharmaceutical products, alternately propelling the demand for isosorbide based medicines in the region.
Furthermore, environmental legislation imposed by regulatory bodies, such as the European Commission and the European Chemicals Agency (ECHA) among other federal-level agencies, characterize the European plastic market. These regulatory rules are challenging and are supposed to contribute to industrial development by pushing producers to improve their processes and develop sustainable products. As a result, the adoption of bio-based ingredients is anticipated to witness a surge, thereby propelling the demand for isosorbide-based products in the region over the forecast period.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe isosorbide market , including forecasts for subscribers. This continent databook contains high-level insights into Europe isosorbide market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account